Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Non-cash Items (2017 - 2025)

Immucell's Non-cash Items history spans 9 years, with the latest figure at $875883.0 for Q4 2025.

  • For Q4 2025, Non-cash Items rose 200.61% year-over-year to $875883.0; the TTM value through Dec 2025 reached $875883.0, up 200.61%, while the annual FY2025 figure was $875883.0, 200.61% up from the prior year.
  • Non-cash Items reached $875883.0 in Q4 2025 per ICCC's latest filing, up from $717859.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $1.3 million in Q1 2021 to a low of -$1.2 million in Q2 2024.
  • Average Non-cash Items over 5 years is $5245.6, with a median of $180500.0 recorded in 2021.
  • Peak YoY movement for Non-cash Items: soared 13123.25% in 2021, then tumbled 1028.29% in 2023.
  • A 5-year view of Non-cash Items shows it stood at $468425.0 in 2021, then crashed by 241.18% to -$661310.0 in 2022, then crashed by 61.97% to -$1.1 million in 2023, then increased by 18.72% to -$870558.0 in 2024, then skyrocketed by 200.61% to $875883.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Non-cash Items are $875883.0 (Q4 2025), $717859.0 (Q3 2025), and $514375.0 (Q2 2025).